NCT07787910Completed
Effect of Virtual Reality on Agitation in Acute Stroke
The Effect of Virtual Reality Application on Agitation in Individuals With Acute Stroke: A Randomized Controlled Single-Blind Study
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
This randomized controlled, single-blind study evaluates the effect of a Virtual Reality (VR) application on agitation levels and physiological vital signs in patients with acute stroke. Participants are randomly assigned to an intervention group receiving standard clinical care plus structured VR sessions, or a control group receiving standard clinical care alone. Agitation scores and vital signs (heart rate, blood pressure, respiratory rate, and oxygen saturation) are measured pre- and post-intervention to evaluate the outcomes of VR therapy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 68 (actual)
- First submitted
- 18 Aug 2026
- Start date
- 8 Sept 2025
- Primary completion date
- 16 Jun 2026
- Lead sponsor
- Ankara Etlik City Hospital
- Diseases
- Stroke
- NCT number
- NCT07787910
What you commit to
- Study type: Interventional
- Participants enrolled: 68
- From 8 Sept 2025 to the primary completion date, 16 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of nausea and vomiting
- Mobility restriction and sensitivity to claustrophobia
- Presence of delirium
- Presence of schizophrenia and dementia
- Presence of vertigo and Meniere's disease
- Having a pain score of 1 point or higher
- Having facial damage to the extent that a virtual reality headset cannot be worn
Who the study is looking for
- \* Individuals who have passed 48 hours post-acute CVA (being in the acute phase of stroke treatment, stroke duration not exceeding the first 4 weeks)
- Having a score of 0 on the Wong-Baker FACES Pain Rating Scale
- Having a score of at least +2 or higher on the Richmond Agitation-Sedation Scale (RASS)
- Being 18 years of age or older
- Having a GCS score of 13 or higher
- Having no hearing or visual impairments
- Not being in contact isolation due to a contagious disease
- Being literate in Turkish
- Not being administered sedation
- Being awake and hemodynamically stable
- Being able to sit in high Fowler's position
- Individuals without mechanical ventilation support
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Çankırı Karatekin University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.